Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

HNO International (HNOI) Research & Development (2022 - 2024)

HNO International (HNOI) has disclosed Research & Development for 3 consecutive years, with $5901.0 as the latest value for Q1 2024.

  • For the quarter ending Q1 2024, Research & Development rose 6384.62% year-over-year to $5901.0, compared with a TTM value of $23927.0 through Jan 2024, changed N/A, and an annual FY2023 reading of $43049.0, down 18.65% over the prior year.
  • Research & Development was $5901.0 for Q1 2024 at HNO International, down from $15002.0 in the prior quarter.
  • Across five years, Research & Development topped out at $15002.0 in Q3 2023 and bottomed at $91.0 in Q1 2023.
  • Average Research & Development over 3 years is $5981.8, with a median of $4417.0 recorded in 2022.
  • Peak annual rise in Research & Development hit 6384.62% in 2024, while the deepest fall reached 6384.62% in 2024.
  • Year by year, Research & Development stood at $2933.0 in 2022, then surged by 411.49% to $15002.0 in 2023, then plummeted by 60.67% to $5901.0 in 2024.
  • Business Quant data shows Research & Development for HNOI at $5901.0 in Q1 2024, $15002.0 in Q3 2023, and $91.0 in Q1 2023.